Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Prophylactic surgery in Lynch syndrome.

V Celentano1, G Luglio, G Antonelli

  • 1Department of General, Oncologic and Video-Assisted Surgery, University "Federico II", Via S. Pansini, 5, 80131, Naples, Italy. valeriocelentano@yahoo.it

Techniques in Coloproctology
|February 3, 2011
PubMed
Summary

Lynch syndrome (LS) increases colorectal and endometrial cancer risks. Genetic testing guides decisions on risk-reduction strategies like colectomy and prophylactic surgeries for mutation carriers.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical diagnosis and treatment of mechanical complications of the ileoanal pouch-A video vignette.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2026
Same author

A novel sphincter-sparing procedure for seton removal in complex perianal fistulas: the FiLaFlap technique.

Techniques in coloproctology·2025
Same author

First description of endoscopic dilation of stricturing Kono-S anastomosis in Crohn's disease.

Techniques in coloproctology·2025
Same author

A step-by-step guide to ileoanal J-pouch MRI interpretation.

Techniques in coloproctology·2023
Same author

Molecular study of the presence and transcriptional activity of HPV in semen.

Journal of endocrinological investigation·2023
Same author

Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and -B bronchiolitis before and after pandemic restrictions in Rome.

The Journal of infection·2023

Area of Science:

  • Genetics
  • Oncology
  • Hereditary Cancer Syndromes

Background:

  • Lynch syndrome (LS) arises from germline mutations in DNA mismatch repair genes.
  • LS is an autosomal dominant condition accounting for 2-5% of colorectal cancer (CRC) cases.
  • Mutation carriers face a 60-85% lifetime risk of CRC and a significant risk of other LS-associated cancers.

Purpose of the Study:

  • To review cancer risk-reduction strategies for Lynch syndrome patients.
  • To emphasize personalized management decisions based on patient factors and preferences.
  • To highlight the significant risk of endometrial cancer in women with LS.

Main Methods:

  • Literature review of Lynch syndrome management.
  • Analysis of cancer risks associated with mismatch repair gene mutations.

Related Experiment Videos

Last Updated: Jun 4, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

  • Discussion of surgical and surveillance strategies.

    • Main Results:

    • Colectomy significantly reduces the risk of a second CRC.
    • Women with LS have a 40-60% lifetime risk of endometrial adenocarcinoma.
    • Early-onset and multiple cancers are characteristic of LS.

    Conclusions:

    • Optimal management for LS requires careful consideration of individual patient factors.
    • Genetic counseling is crucial for discussing colectomy and, for women, prophylactic hysterectomy and oophorectomy.
    • Proactive cancer risk management is essential for Lynch syndrome mutation carriers.